Juv & #233;derm, Allergan Inc.’s wrinkle remover acquired in last year’s $3.2 billion buy of Inamed Corp., now is selling nationwide, the Irvine drug maker said Wednesday.
The rollout is a followup to an “experience trial” involving cosmetic surgeons that started in the fall.
Allergan is looking to sell Juv & #233;derm alongside its Botox wrinkle remover. The company plans an advertising push aimed at consumers for Juv & #233;derm, Chief Executive David Pyott told the Business Journal in an earlier interview.
The Juv & #233;derm marketing is designed to put the brand into “the household consciousness of America,” said Robert Grant, president of Allergan Medical, the division Juv & #233;derm falls under.
